We have investigated the effect of orally administered Lactobacillus casei Shirota (L. casei) on immunological memory, as measured by delayed-type hypersensitivity (DTH) and acquired cellular resistance (ACR). The studies were performed in animal models in which the animals were rendered immune by a primary Listeria monocytogenes infection. It was shown that orally administered viable L. casei, and not heat-killed L. casei, enhanced significantly the antigen-specific DTH at 24 and 48 h in Wistar rats, Brown Norway rats, and BALB/c mice in a time-and dose-dependent fashion. L. casei had to be administered at least 3 days prior to the DTH assay at a daily dose of 10 9 CFU in order to induce significant effects. Long-term administration of 10 9 CFU of viable L. casei resulted in enhanced ACR, as demonstrated by reduced L. monocytogenes counts in the spleen and liver and diminished serum alanine aminotransferase activity after reinfection. Enhancement of cellmediated immunological immune responses by L. casei was further established in an adoptive transfer study. Naïve recipient BALB/c mice, which were infused with nonadherent, immunized spleen cells from L. casei-fed donor BALB/c mice, showed significantly enhanced DTH responses at 24 and 48 h compared to recipient mice which received spleen cells from control donor mice. In conclusion, orally administered L. casei enhanced cell-mediated immunological memory responses. The effects relied on lactobacillus dose and viability as well as timing of supplementation and, further, appeared to be independent of host species or genetic background.
Various cells of the innate and acquired immune system interact in a concerted fashion to constitute a sophisticated set of responses to protect the physiological integrity of the host against infectious agents and tumors. Inappropriate orchestrated immune responses lead to, e.g., autoimmune and allergic disease states as well as enhanced susceptibility to infections. Different compounds are known which have the capacity to enhance or decrease biological responses of the immune system in order to restore disturbed immune responses or to elevate resistance to infectious agents. These compounds can be classified as so-called immunomodulators or biologic response modifiers (23) .
Lactobacilli form a source of potential modulators of the immune system. It has been demonstrated that specific Lactobacillus strains can modulate host immunity, which positively correlates with enhanced resistance to various viral and bacterial infections (9, 20, 24) . The immunomodulating effects are dependent on various factors, such as intrinsic adjuvanticity properties (21) , dose (13, 31) , viability (16, 20, 30) , route and timing of administration of the specific Lactobacillus strains (i.e., oral versus parenteral), and the physiological state and genetic background of the host (20) .
Previous results from our group established that 10 9 orally administered viable Lactobacillus casei Shirota strain YIT9029 (L. casei) bacteria given daily enhanced Trichinella spiralis antigen-specific immunoglobulin G2b (IgG2b) and delayed-type hypersensitivity (DTH) responses in Brown Norway and Wistar rats in an oral infection model of T. spiralis (8) . The immunostimulating activity of Lactobacillus casei Shirota was also observed in a rat model of food-borne Listeria monocytogenes infection. It was shown in orally Listeria-infected rats that ingestion of L. casei enhanced the DTH reaction (7) . From these studies, and based on the described immune cell populations involved in DTH responses (29) , it was asserted that orally supplemented L. casei could exert a direct effect on T-helper-1-cell immunity by modulating the amount and activity of antigen-specific T lymphocytes and/or could exert an indirect effect on T-lymphocyte activity through stimulation of other cell types, such as phagocytes.
Collectively our studies prompted further examination of the effect of orally administered Lactobacillus casei Shirota strain YIT9029 on cell-mediated immunity in an animal model of systemic L. monocytogenes infection. Rats and mice, which are sublethally infected with viable L. monocytogenes, generate DTH and acquired cellular resistance (ACR) during the course of the infection (29, 36) . ACR provides long-lasting, protective immunity to reinfection and can be measured as the pathogenic load after reinfection. Although the correlation between DTH and ACR remains controversial, they are both inversely related to the immune status of the host. Measurement of DTH and ACR forms a reliable method for examining the effects of orally administered lactobacilli on immunological memory.
In a parenteral Listeria monocytogenes infection model we studied the effects of orally administered Lactobacillus casei Shirota strain YIT9029 on T-cell-dependent immune responses by measurement of Listeria-specific DTH reaction and ACR in rechallenge and adoptive transfer studies. Since immune-modulating effects may rely on a range of factors, we investigated whether the effects induced by L. casei ingestion were dependent on the lactobacillus dose, viability, and administration timing as well as host genetics. In all experiments with actively infected Wistar rats, Brown Norway rats, and BALB/c mice, it was shown that ingestion of viable L. casei enhanced immunological memory, as determined by DTH and ACR, in a dose-, viability-, and timing-dependent fashion. Since DTH, ACR, and transfer of DTH are T-cell-dependent phenomena, it is suggested that L. casei-induced immunomodulation could be attributed, at least partly, to T memory cells.
the animals (n ϭ 6 per group) were daily administered in 0.5-ml suspensions, which contained 10 9 CFU of viable L. casei. Control animals received saline instead of lactobacilli. At day 10 postinfection (t ϭ 10), the L. monocytogenesspecific DTH was measured.
Administration timing. Starting 10 days before (t ϭ Ϫ10) or 7 days after (t ϭ 7) the subcutaneous L. monocytogenes infection, rats were daily administered 0.5-ml suspensions with 10 9 CFU of viable L. casei. Control animals received saline instead of lactobacilli (n ϭ 6 rats per group). At t ϭ 7, the host has completely cleared the bacterial pathogen (data not shown), which means that the control and experimental groups have been exposed to the same amounts of Listeria antigen, since the animals were not L. casei treated before day 7 postinfection. Differences found in DTH responses at day 10 would be due only to ingestion of L. casei from day 7 till day 10 postinfection. At day 10 post infection (t ϭ 10), L. monocytogenes-specific cell-mediated immunity was measured using the DTH assay.
Lactobacillus dose, viability, and administration timing. Starting 7 (t ϭ 7), 8 (t ϭ 8), or 9 (t ϭ 9) days after the subcutaneous L. monocytogenes infection, rats were daily administered 0. Adoptive transfer of immunity. Starting 10 days previously (t ϭ Ϫ10), subcutaneously L. monocytogenes-infected donor mice received orally 10 9 CFU of L. casei or saline per day (n ϭ 10 mice per group). Seven days (t ϭ 7) after the primary L. monocytogenes infection, single-cell suspensions were prepared from the spleens of donor mice. After passage over a column packed with glass wool fiber, 10 8 wool-nonadherent spleen cells of five mice of each group were infused via the orbital plexus into syngeneic naive recipients. The recipient mice received no lactobacilli. Twenty-four hours after the transfer (t ϭ 8), the DTH was measured in the recipient mice and the remaining five donor mice of each group. Twenty-four and forty-eight hours after the challenge, the increase in ear thickness was measured. Five days after setting the DTH assay (t ϭ 13), all mice were reinfected with live L. monocytogenes. The mice were killed 24 h later and analyzed for L. monocytogenes counts in the liver and spleen. ACR was determined by the capacity to eliminate L. monocytogenes cells after challenge.
DTH assay. Animals in the experimental and control groups were challenged in left and right ear pinnas with 25 l (10 7 CFU) (for rats) 10 l (10 7 CFU) of heat-killed L. monocytogenes (HKLM) under light ether anesthesia. The application and preparation of HKLM in DTH assays have been described in previous studies (1, 12, 14) . The absolute increase in ear thickness was measured with a digital engineer's micrometer (Mitutoyo, Veenendaal, The Netherlands) 24 and 48 h after challenge. The swelling was calculated according to the following equation: net swelling ϭ (T 24 Ϫ T 0 ) Ϫ (P 24 Ϫ P 0 ); T 0 is thickness of ear before HKLM challenge, T 24 is thickness of ears 24 h after HKLM antigen challenge, P 0 is thickness of ear before phosphate-buffered saline injection, and P 24 is thickness of ear 24 h after phosphate-buffered saline injection. The same type of equation for DTH measurements at 48 h after challenge was performed. It was shown that challenging the ear pinnas in noninfected L. casei-fed rats with heat-killed L. monocytogenes or challenging the ear pinnas of L. monocytogenes-immunized rats with heat-killed L. casei did not result in a significant net swelling response. This excludes possible cross-reactivity of L. monocytogenes antigens with L. casei antigens.
Bacteriological analysis. Spleens and livers were removed aseptically from the animals. The numbers of viable L. monocytogenes were determined by culturing 100 l of serial 10-fold dilutions of organ homogenates in saline on MOA plates. The numbers of L. monocytogenes bacteria were expressed as CFU per gram of spleen and/or liver. Detection limit was 100 CFU/g of tissue.
ALT. ALT levels in rate serum were analyzed with an automated chemistry analyzer (Beckman Synchron CX7; Beckman-Coulter Ned., Mijdrecht, The 
RESULTS
Host genetics and the effects of oral L. casei administration on DTH. Figure 1 shows that L. casei, following oral delivery, significantly enhanced the L. monocytogenes-specific DTH response in Wistar rats at 24 h (P Ͻ 0.05) and 48 h (P Ͻ 0.05), compared to results for control animals. In a parallel study it was shown that orally administered L. casei enhanced significantly the expression of DTH at 24 h (P Ͻ 0.05) and 48 h (P Ͻ 0.05) in the Brown Norway rats (Fig. 1) . Further, in two experiments with L. monocytogenes-immunized BALB/c mice, it was demonstrated that L. casei ingestion enhanced the antigen-specific DTH in rats. In the first experiment the DTH was significantly enhanced at 24 h (P Ͻ 0.01) and 48 h (P Ͻ 0.01) after challenging the ear pinna (Fig. 1) . In the second experiment DTH values in lactobacillus-treated mice were significantly higher at 24 h (P Ͻ 0.001) and 48 h (P Ͻ 0.05) ( Table 1) . In these experiments a dose of 10 9 CFU of viable L. casei was orally administrated on a daily basis, starting 10 days prior to the subcutaneous L. monocytogenes infection.
The effect of L. casei administration timing on DTH. Starting daily, oral L. casei administration at a dose of 10 9 CFU, 10 days prior to as well as 7 days after the primary Listeria monocytogenes infection in Wistar rats, resulted in significantly enhanced antigen-specific DTH expression, as shown in Fig. 2 . The magnitude of the DTH responses at 24 and 48 h was comparable for the two groups of rats which received L. casei 20 or 3 consecutive days prior to the DTH assay.
The effect of oral administration of 10 9 CFU of viable L. casei 3 days prior to the DTH assay in Wistar rats was reproduced, as shown in Fig. 3 . A significantly enhanced Listeriaspecific DTH reaction was measured at 24 h (P Ͻ 0.05) and 48 h (P Ͻ 0.01) in animals which received L. casei starting 3 days before the DTH assay. DTH values at 24 and 48 h after ingestion of 10 9 CFU of lactobacilli at 2 days or 1 day prior to viable L. monocytogenes bacteria. Starting 10 days before infection, the mice received a daily dose of L. casei (n ϭ 10) or saline (n ϭ 10). Nonadherent (10 8 ) spleen cells (Inf Spl) from five BALB/c mice were infused into syngeneic naive recipients 7 days (t ϭ 7) after infection. Twenty-four hours after the transfer (t ϭ 8), the L. monocytogenes-specific DTH was set and was determined 24 and 48 h later for the five recipient mice and the five remaining donor mice of the respective experimental and control groups. Five days after setting of the DTH assay (t ϭ 13), all mice were challenged intraperitoneally with 5 ϫ 10 7 viable L. monocytogenes bacteria. The mice were killed 24 h later, and counts of viable L. monocytogenes in the spleen were determined. Listeria counts are expressed as geometric means.
b Asterisks indicate significant difference ‫,ء(‬ P Ͻ 0.05; ‫,ءء‬ P Ͻ 0.01; ‫,ءءء‬ P Ͻ 0.001) from the respective control group as calculated with Student's t test.
VOL. 10, 2003 ENHANCED IMMUNOLOGICAL MEMORY 61 the DTH assay did not significantly differ from those for control rats. Decreasing the number of lactobacillus applications prior to the DTH assay resulted in a strong, but not significant, tendency to correlate with decreasing DTH values at 24 h. This correlation was significant at 48 h (r ϭ 0.55; P Ͻ 0.05). (Table 2 ). Immunologically primed animals responded to reinfection in a more vigorous and effective manner, as shown in Table 2 . Unprimed control animals (control-1) had approximately 10 times higher Listeria counts in the visceral organs, spleen (P Ͻ 0.01), and liver (P Ͻ 0.01), as well as significantly higher serum ALT activity (P Ͻ 0.01) than primed control animals (control-2). Further, L. monocytogenes growth was not affected by longterm oral administration of heat-killed L. casei. Serum ALT activity was significantly lower in two (out of three) groups of animals which were fed viable L. casei Shirota at a dose of 10 9 CFU per day for 63 consecutive days, compared to the control group (control-2), as shown in Table 2 groups did not affect significantly the ALT activity. In spite of that, ALT values were significantly correlated with bacterial load in the liver (r ϭ 0.75; P Ͻ 0.01).
Adoptive transfer of immunity. It was shown that expression of antigen-specific DTH was significantly enhanced in recipient BALB/c mice which received nonadherent spleen cells from L. casei-fed donor BALB/c mice. In Fig. 4 , it is shown that DTH was enhanced at 24 h (P Ͻ 0.01) and 48 h (P Ͻ 0.05). The magnitude of the DTH values of recipient mice, as depicted in Fig. 4 , was comparable to DTH values of the remaining, corresponding groups of mice ( Table 1 ) that were assayed parallel to the spleen cell-infused recipient mice, following 7 days after the primary infection with L. monocytogenes. Ten days after the DTH assay, all groups of mice were reinfected with viable L. monocytogenes. Numbers of Listeria bacteria in the spleen appeared reduced, but not significantly, in normal L. casei-fed mice as well as in reconstituted recipients which received spleen cells from L. casei-supplemented donor animals, compared to the respective controls.
DISCUSSION
The immune system can be optimized through oral supplementation of specific Lactobacillus strains (2, 9). Modulation of B-cell-mediated immune responses can be monitored relatively simply by, for instance, measurement of titers of antigenspecific antibody in serum. In vivo measures of T-cell-mediated immunity comprise delayed-type hypersensitivity responses and reinfections with intracellular pathogens, such as L. monocytogenes (11, 36) .
In the present study it is shown that ingestion of a daily dose of 10 9 CFU of live, L. casei Shirota strain YIT9029, starting at least 3 days prior to setting the L. monocytogenes-specific DTH assay, significantly enhances the DTH response at 24 and 48 h in the genetically different Wistar and Brown Norway rats as well as in BALB/c mice ( Fig. 1, 2, and 3) . Brown Norway rats and BALB/c mice are representative for animals which tend to respond immunologically in a more Th2-skewed fashion than Wistar rats (17, 28, 38, 40) . Our observations demonstrated that the effect of L. casei is not dependent on host genetics. Host-independent effects by L. casei have also been shown in previous other studies of our group. With T. spiralis-infected Wistar and Brown Norway rats it was shown that oral L. casei supplementation enhanced both the antigen-specific DTH and serum IgG2b. In our hands, enhancement of antigen-specific DTH by peroral L. casei application has also been observed in a food-borne model of L. monocytogenes (7) . Expression of antigen-specific DTH in rats and mice and of IgG2b responses in rats are reported to be manifestations of Th1-type cellmediated responses (15, 33) . The capacity to stimulate Th1 activity by L. casei has also been suggested in previous in vivo and in vitro studies with mice performed by other groups (18, 25, 37) . From these results it was suggested that oral adminis- 7 viable L. monocytogenes cells, and 36 h later, they were killed and analyzed for L. monocytogenes present in spleen and liver. b ACR is the degree of bacterial elimination in spleen and liver and was assessed by subtracting mean log 10 CFU of indicated challenged groups from mean log 10 CFU of the normal noninfected control rats (control-1).
c Asterisks indicate significant difference ‫,ء(‬ P Ͻ 0.05; ‫,ءء‬ P Ͻ 0.01) from the infected control group (control-2) as calculated with Student's t test.
FIG . 4 . Transfer of L. monocytogenes-specific DTH. BALB/c donor mice were subcutaneously infected with viable L. monocytogenes. Starting 10 days prior to infection, the mice received a daily dose of L. casei or saline. Nonadherent spleen cells from L. casei and control-fed BALB/c mice were infused into syngeneic naive recipients 7 days after infection. Twenty-four hours after the transfer, the L. monocytogenesspecific DTH was set, and it was determined 24 and 48 h later for the recipient mice. Bars represent the means Ϯ standard deviations for five animals per group. Asterisks indicate significant differences ‫,ء(‬ P Ͻ 0.05; ‫,ءء‬ P Ͻ 0.01) from the control group as calculated with Student's t test. ϩ T-helper cells (1, 35, 39) . The in vivo effector assay comprised the transfer of nonadherent spleen cells from L. monocytogenes-infected donor BALB/c mice, which were fed L. casei or control saline, to naive recipients, which were challenged 24 h later in the ear pinna. The results demonstrated that naive recipient mice, which received nonadherent spleen cells from L. casei-fed donor mice, had enhanced DTH responses compared to control animals. This finding supports our view that L. casei ingestion enhances the activity and/or proliferation of T-helper-1 memory cells.
Although the association of DTH and acquired cellular immunity remains controversial, they both are manifestations of T-cell-mediated immunological memory (1, 6, 27, 35, 39) . The kinetics of development and endurance of both responses have been reported to be similar (22) . Presumably, different subsets of T cells are involved in DTH and ACR (1, 26, 39) . Despite the uncertain association between DTH and ACR, it was shown that long-term, i.e., for approximately 8 weeks, oral administration of a daily dose of 10 9 CFU of L. casei enhanced acquired cellular resistance against a reinfection with L. monocytogenes as measured by reduced numbers of bacterial pathogen in the spleen and liver as well as reduced ALT levels in serum, next to the enhancement of DTH. In the transfer studies with mice, the bacterial counts in the spleen also appeared to be decreased after reinfection, albeit this was statistically not significant.
Further, it was shown that the effects of L. casei on immunological memory responses were dose dependent. Incrementally increasing doses of L. casei significantly conveyed higher levels of enhancement of DTH and ACR. A dose of 10 7 L. casei bacteria was shown to be ineffective in modulating DTH or ACR. It is ambiguous whether the effective dose of L. casei is associated with a disparity in sensitivity of the specific cells involved in the measured immune parameters. It has been shown that a specific Lactobacillus rhamnosus strain was able to enhance the phagocytic capacity of white blood cells at a dose of 10 7 , while a 100-times-higher dose of lactobacilli was needed to increase the phagocytic capacity of peritoneal cell preparations, following oral delivery (13) .
In our specific experimental setup with L. monocytogenesinfected rats, it is possible that viable and killed lactobacilli exert different effects, for example, through differential stimulation of dendritic cell subsets (DC1 versus DC2), which control the directional development of T-helper-cell phenotypes (4, 19) . Another explanation for differential effects of viable and dead L. casei, as shown in our studies, could be that immune stimulation by L. casei is mediated by heat-sensitive structures on the bacterial surface. Data obtained by Haller et al. showed that higher concentrations of heat-killed lactobacilli were needed to induce the same tumor necrosis factor alpha production by monocytes as was induced by live lactobacilli (16) . It was speculated from these studies that heat-killed lactobacilli express less undisturbed surface modulins (i.e., peptidoglycans or lipoteichoic acids) which can be recognized by pattern recognition receptors (e.g., CD14 or toll-like receptors) on various antigen-presenting cells (10, 34) .
In summary, the present study endorses the idea that orally administered L. casei Shirota strain YIT9029 enhances cellmediated immunological memory responses, as determined by DTH, ACR, and adoptive transfer of DTH in an L. monocytogenes infection model. Since DTH, ACR, and transfer of DTH are T-cell-dependent phenomena, it is suggested L. casei-induced immunomodulation is mediated, at least partly, by memory T cells. Still, the nature of the cells, in terms of cytokine profiles and cell surface markers, in the observed effects remains to be established. Nevertheless, the effect of L. casei on cell-mediated memory responses relied on the timing of administration, was dose dependent, and possibly was imparted through a heat-sensitive constituent of L. casei. The effects of viable L. casei appeared to be independent of the responding host species and genetic background.
